Bone Grafts and Substitutes Market by Product and Application - Global Industry Analysis and Forecast to 2025

Report Code : HC06134

Bone grafts and substitutes are used to repair bone fractures, bone formation, and osseous reconstruction as these materials are having osteoconductive and osteoinductive properties. These grafts and substitutes are made up from synthetic and natural materials, and animal and human-derived tissues. An ideal bone graft and substitutes has to be bioabsorbable, osteoinductive, biocompatible, osteoconductive, and cost-effective. Therefore, these are commercially available for orthopedic applications such as joint reconstruction, spinal fusion, and sports related injuries. As per the report published by American Academy of Orthopedic Surgeons, in U.S., around 500,000 bone grafting surgeries are performed every year. Of these, almost half of the surgeries are related to spinal fusion. These large number of procedures lead to rise in demand for musculoskeletal tissue donation and a shortage of cadaver material.

Rise in number of orthopedic surgeries, rapidly aging population, increase in adoption of advanced products, and growing demand for minimal invasive procedures are set to drive the global market for bone grafts and substitutes. Additionally, increase availability of products with high osteoinductive and osteoconductive properties will further contribute to the market growth. Moreover, the high demand for bone grafts and substitutes in orthopedic industry coupled with rise in adoption of these grafts and substitutes in different orthopedic applications such as joint reconstruction, trauma, craniomaxillofacial, and spinal fusion. However, stringent approval process and high cost of bone grafting procedures coupled with ethical issues related to these surgeries will hamper the market growth during the forecast period.

Elderly population is highly susceptible to orthopedic injuries due to weakening of bones. As per the data revealed by United Nations Department of Economic and Social Affairs, globally, the share of people aged 60 years or above increased from 9.2% in 1990 to 11.7% in 2013 and this share is projected to reach 21.1% by 2050. It further states that the number of older people (aged 60 years or above) worldwide were 841 million in 2013 and this number is projected to grow more than 2 billion by 2050. Thus, the rapidly aging population will accelerate the demand for orthopedic procedures in near future. Such high target population will bring in ample growth opportunities for the development of advanced products which can be implanted through minimal invasive surgeries. Moreover, large number of product approvals and launches will further contribute to the market growth. For instance, in November 2015, CeraPedics, an orthobiologics company, obtained Premarket Approval (PMA) application for its “i-FACTOR Peptide Enhanced Bone Graft”. This graft can be used for the treatment of degenerative cervical disc related disorders. Likewise, in September 2015, Wright Medical Group Inc., obtained premarket approval for its Augment bone graft from FDA. This graft can be used in ankle or hind foot fusion procedures. Thus, introduction of technologically advanced products is set to propel the market growth.

Major players operating in this market are Arthrex, Inc, Johnson & Johnson, Baxter International Inc., Wright Medical Group N.V., Xtant Medical Holdings, Inc., Zimmer Biomet Holdings, Inc., Medtronic Plc., Stryker Corporation, Musculoskeletal Transplant Foundation, and Integra Lifesciences Holdings Corporation. These companies are highly focused on expanding their geographical presence through establishing strong distribution channels and direct sales network.

Bone Grafts and Substitutes Market Segmentation:

By Product:

  • Bone Grafts Substitutes
  • Synthetic Bone Grafts
  • Bone Morphogenic Proteins
  • Cell-based Matrices
  • Allografts
  • Demineralized Bone Matrix
  • Machined Allografts

By Application:

  • Joint Reconstruction
  • Dental Bone Grafting
  • Trauma
  • Craniomaxillofacial
  • Spinal Fusion

By Region:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of The World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

 

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Licesnces Type

For Any Further Assistance

*
*
*